Literature DB >> 22568953

Regulation and misregulation of Eph/ephrin expression.

Dina N Arvanitis1, Alice Davy.   

Abstract

The erythropoietin-producing hepatocellular (Eph) receptors form the largest family of receptor tyrosine kinases. Upon interaction of the Eph receptors with their ligands the ephrins, signaling cascades are initiated downstream of both receptor and ligand, a feature known as bidirectional signaling. The Eph receptors and ephrin ligands mediate important roles in embryonic development, particularly in establishing tissue organization by mediating cell adhesion or cell repulsion. In several adult tissues, at least one Eph/ephrin pair is found to play critical roles in tissue physiology and homeostasis. In recent years numerous members of this family have gained considerable attention since changes in their expression levels are a typical feature in cancer cells. Despite the fact that Eph/ephrin developmental expression profiles are well documented, little is known on transcriptional and post-transcriptional mechanisms that permits their highly specific, graded, complementary or overlapping expression patterns. Therefore understanding the transcriptional and post-transcriptional mechanisms regulating Eph/ephrin expression has far-reaching significance in biology. This review provides an overview of the mechanisms regulating Eph/ephrin expression. We highlight important emerging mechanisms of Eph/ephrin regulation or misregulation such as epigenetics and miRNAs.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22568953      PMCID: PMC3499312          DOI: 10.4161/cam.19690

Source DB:  PubMed          Journal:  Cell Adh Migr        ISSN: 1933-6918            Impact factor:   3.405


  99 in total

1.  Constitutive activation of the Raf-MAPK pathway causes negative feedback inhibition of Ras-PI3K-AKT and cellular arrest through the EphA2 receptor.

Authors:  C W Menges; D J McCance
Journal:  Oncogene       Date:  2007-12-03       Impact factor: 9.867

Review 2.  Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight?

Authors:  Witold Filipowicz; Suvendra N Bhattacharyya; Nahum Sonenberg
Journal:  Nat Rev Genet       Date:  2008-02       Impact factor: 53.242

3.  Specification of motor axon trajectory by ephrin-B:EphB signaling: symmetrical control of axonal patterning in the developing limb.

Authors:  Victor Luria; Dayana Krawchuk; Thomas M Jessell; Ed Laufer; Artur Kania
Journal:  Neuron       Date:  2008-12-26       Impact factor: 17.173

Review 4.  Eph-ephrin bidirectional signaling in physiology and disease.

Authors:  Elena B Pasquale
Journal:  Cell       Date:  2008-04-04       Impact factor: 41.582

5.  Zic2 promotes axonal divergence at the optic chiasm midline by EphB1-dependent and -independent mechanisms.

Authors:  Cristina García-Frigola; Maria Isabel Carreres; Celia Vegar; Carol Mason; Eloísa Herrera
Journal:  Development       Date:  2008-04-16       Impact factor: 6.868

6.  MicroRNA-210 modulates endothelial cell response to hypoxia and inhibits the receptor tyrosine kinase ligand Ephrin-A3.

Authors:  Pasquale Fasanaro; Yuri D'Alessandra; Valeria Di Stefano; Roberta Melchionna; Sveva Romani; Giulio Pompilio; Maurizio C Capogrossi; Fabio Martelli
Journal:  J Biol Chem       Date:  2008-04-16       Impact factor: 5.157

Review 7.  Eph-ephrin signalling in adult tissues and cancer.

Authors:  Anna Merlos-Suárez; Eduard Batlle
Journal:  Curr Opin Cell Biol       Date:  2008-03-18       Impact factor: 8.382

8.  EphA2 is an essential mediator of UV radiation-induced apoptosis.

Authors:  Guoqi Zhang; Ching-Ni Njauw; Jong Min Park; Chie Naruse; Masahide Asano; Hensin Tsao
Journal:  Cancer Res       Date:  2008-03-15       Impact factor: 12.701

9.  Enhancement of lymphocyte migration and cytokine production by ephrinB1 system in rheumatoid arthritis.

Authors:  Takuya Kitamura; Yukihito Kabuyama; Akihisa Kamataki; Miwako K Homma; Hideo Kobayashi; Shigeo Aota; Shin-ichi Kikuchi; Yoshimi Homma
Journal:  Am J Physiol Cell Physiol       Date:  2007-10-17       Impact factor: 4.249

10.  Comparative 3'UTR analysis allows identification of regulatory clusters that drive Eph/ephrin expression in cancer cell lines.

Authors:  Jennifer Winter; Stefan Roepcke; Sven Krause; Eva-Christina Müller; Albrecht Otto; Martin Vingron; Susann Schweiger
Journal:  PLoS One       Date:  2008-07-23       Impact factor: 3.240

View more
  15 in total

1.  Spatial organization of EphA2 at the cell-cell interface modulates trans-endocytosis of ephrinA1.

Authors:  Adrienne C Greene; Samuel J Lord; Aiwei Tian; Christopher Rhodes; Hiroyuki Kai; Jay T Groves
Journal:  Biophys J       Date:  2014-05-20       Impact factor: 4.033

2.  Identification of Potential Gene Network Associated with HCV-Related Hepatocellular Carcinoma Using Microarray Analysis.

Authors:  Yang Cheng; Jian Ping; Jianjie Chen
Journal:  Pathol Oncol Res       Date:  2017-07-01       Impact factor: 3.201

3.  Eph/ephrin signaling in cancer: intricate, puzzling and ... fascinating!

Authors:  Luis Miguel Alonso-Colmenar
Journal:  Cell Adh Migr       Date:  2012-03-01       Impact factor: 3.405

4.  Neuronopathic Gaucher disease: dysregulated mRNAs and miRNAs in brain pathogenesis and effects of pharmacologic chaperone treatment in a mouse model.

Authors:  Nupur Dasgupta; You-Hai Xu; Ronghua Li; Yanyan Peng; Manoj K Pandey; Stuart L Tinch; Benjamin Liou; Venette Inskeep; Wujuan Zhang; Kenneth D R Setchell; Mehdi Keddache; Gregory A Grabowski; Ying Sun
Journal:  Hum Mol Genet       Date:  2015-09-29       Impact factor: 6.150

Review 5.  Eph receptors and ephrins: therapeutic opportunities.

Authors:  Antonio Barquilla; Elena B Pasquale
Journal:  Annu Rev Pharmacol Toxicol       Date:  2014-10-03       Impact factor: 13.820

6.  Prospective Proteomic Study Identifies Potential Circulating Protein Biomarkers for Colorectal Cancer Risk.

Authors:  Xiaohui Sun; Xiao-Ou Shu; Qing Lan; Monika Laszkowska; Qiuyin Cai; Nathaniel Rothman; Wanqing Wen; Wei Zheng; Xiang Shu
Journal:  Cancers (Basel)       Date:  2022-07-03       Impact factor: 6.575

7.  A review on Eph/ephrin, angiogenesis and lymphangiogenesis in gastric, colorectal and pancreatic cancers.

Authors:  Julia Rudno-Rudzińska; Wojciech Kielan; Ewelina Frejlich; Krzysztof Kotulski; Wojciech Hap; Krzysztof Kurnol; Przemysław Dzierżek; Marcin Zawadzki; Agnieszka Hałoń
Journal:  Chin J Cancer Res       Date:  2017-08       Impact factor: 5.087

Review 8.  Beyond boundaries--Eph:ephrin signaling in neurogenesis.

Authors:  J Laussu; A Khuong; J Gautrais; A Davy
Journal:  Cell Adh Migr       Date:  2014       Impact factor: 3.405

9.  Therapy of pancreatic cancer via an EphA2 receptor-targeted delivery of gemcitabine.

Authors:  Bridget A Quinn; Si Wang; Elisa Barile; Swadesh K Das; Luni Emdad; Devanand Sarkar; Surya K De; Susan Kharagh Morvaridi; John L Stebbins; Stephen J Pandol; Paul B Fisher; Maurizio Pellecchia
Journal:  Oncotarget       Date:  2016-03-29

Review 10.  Eph receptors: the bridge linking host and virus.

Authors:  Jia Wang; Xiang Zheng; Qiu Peng; Xuemei Zhang; Zailong Qin
Journal:  Cell Mol Life Sci       Date:  2019-12-31       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.